Arca Biopharma | ABIO - Pre Tax Profit


Arca Biopharma reported $-31.82M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -6.26M 1.52M Dec/2025
Amgen USD 2.08B 570M Mar/2026
Arca Biopharma USD -31.82M 2.24M Mar/2026
Biogen USD 647.3M 269.6M Jun/2026
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cipla INR 10.82B 3.33B Jun/2026
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD -7.66M 64.51M Mar/2026
CSL USD 2.61B 1.21B Dec/2025
Cytokinetics USD -206.03M 23M Mar/2026
Daiichi Sankyo JPY -6.52B 113.25B Mar/2026
Gilead Sciences USD -7.53B 10.11B Jun/2026
GlaxoSmithKline GBP 2.68B 532M Jun/2026
Grifols EUR 257.85M 190.87M Dec/2024
Laboratory Of America USD 8.61B 121.8M Jun/2026
Myriad Genetics USD 4.6M 3.4M Dec/2025
Otsuka Holdings JPY 130.23B 54.96B Mar/2026
Pfizer USD -653M 5.84B Jun/2026
United Therapeutics USD 372.7M 54.4M Jun/2026